TL;DR: 5-alpha reductase inhibitors quietly change sebum, hair, and skin behavior over months. Here is a skincare pairing guide for finasteride and dutasteride users.
TL;DR. Finasteride and dutasteride are 5-alpha reductase inhibitors prescribed for male pattern hair loss and benign prostatic hyperplasia. They reduce dihydrotestosterone (DHT) systemically, which changes sebum output, body hair pattern, and sometimes facial skin texture more than most prescribers mention. The skincare answer is gentler, less stripping, and recalibrated as oil production drops over months.
The complaint I get from men on finasteride two to four months into treatment: “My skin is suddenly less oily and my forehead is dry for the first time in my life.” The drug is doing exactly what it is designed to do. The skincare needs to follow.
What these drugs actually do
Finasteride (1 mg for hair loss, 5 mg for prostate) and dutasteride (0.5 mg) block the enzyme 5-alpha reductase, which converts testosterone to dihydrotestosterone. DHT is the androgen most responsible for both pattern hair loss in scalp and excess sebum production. Reducing it slows hair loss for around 80 percent of men who use these drugs consistently. It also reduces facial and body sebum production meaningfully over three to six months.
The skin effects are mostly gradual. Sebum output drops, the forehead and nose become less shiny by midday, and adult hormonal acne (if present) often improves alongside. Some patients report dryness, particularly in winter or on the forehead and scalp. Body hair may thin somewhat over years of use, which is part of the same biology.
There are documented but rare reports of persistent sexual side effects (post-finasteride syndrome) and mood changes. The dermatological effects discussed here are separate from those concerns and well established in the prescribing literature.
What helps
The routine usually shifts from “oily skin routine” to “normal-to-dry skin routine” over the first six months of treatment.
A gentle, low-pH cleanser morning and evening. Skip foaming sulfate cleansers if you were using one for oily skin. The skin does not need them anymore by month three.
Niacinamide 4 to 5 percent serum in the morning. Calming, mildly sebum-regulating, and pairs well with most other actives. The benefit is more about post-inflammatory pigment from prior acne than ongoing oil control.
A lightweight moisturizer in months one to two, transitioning to a richer ceramide-based moisturizer by months three to four as oil output drops. Many men who never used moisturizer pre-treatment find they need one for the first time around month four.
SPF 30 or higher every morning. Standard daily UV protection is more important on these drugs than people realize, because the post-inflammatory pigment from any future breakouts lasts longer in skin that is also slower to turn over.
Adapalene 0.1 or 0.3 percent two to three nights per week if there is residual hormonal acne. Adapalene works well alongside DHT-lowering therapy because they address different mechanisms.
The contrarian take: these pills change your sebum more than your routine ever did
I have watched men spend years rotating through oily-skin products that never quite solved the shine, then start finasteride and find their oil control problem resolved within four months by a drug they took for their hair. The lesson is not that everyone should take finasteride for shine; the lesson is that sebum production is hormonally driven in a way that topical products cannot fully override. If you are on these drugs already and your old oily-skin routine is now stripping your face, the drug is doing the work and the routine is fighting it.
Reassess every three months for the first year. The skin you had at the start of treatment is not the skin you will have at month six.
When to see a dermatologist
You may already be seeing one if finasteride was prescribed for hair loss. Between visits, contact them or your primary care if you develop persistent dryness that does not respond to moisturizer changes, new skin sensitivities you did not have before, unexpected gynecomastia (rare on finasteride 1 mg but possible on higher doses), or any new mood symptoms. A general dermatologist can adjust the skincare routine; questions about persistent sexual side effects or discontinuation belong with the prescribing physician.
Topical finasteride at 0.25 percent is an emerging alternative that delivers the hair benefit with substantially lower systemic DHT suppression. For patients concerned about systemic side effects, it is worth discussing as an option.
The real numbers
A 2018 review in the British Journal of Dermatology reported that oral finasteride at 1 mg per day reduces serum DHT by approximately 70 percent and scalp DHT by approximately 60 percent within one to two months of starting treatment. Sebum production drops by an estimated 30 to 40 percent on the face over three to six months of consistent use. Dutasteride at 0.5 mg per day reduces DHT by approximately 90 percent and produces somewhat stronger sebum and hair effects, though it is FDA-approved for prostate use rather than hair loss in the United States.
For more on related routines, see adult acne after 30, oily skin routine, and the adult acne tag hub.
FAQ
Will my acne come back if I stop? Often yes, within three to six months as DHT levels return to baseline.
How long until I see less oil? Modest reduction at month two, clearer differences at month four to six.
Can I combine finasteride with topical minoxidil? Yes, this is the most common stacked regimen for pattern hair loss and the combination is well studied.
Tool: eyebrow growth protocol — evidence-ranked: bimatoprost, peptide serums, microneedling — and what NOT to spend money on.
Is dutasteride more effective for skin? It produces stronger DHT suppression and somewhat stronger sebum reduction, but with higher rates of side effects in some patients.
What about topical finasteride? It works for hair loss with substantially less systemic exposure. Useful option for men concerned about side effects.
Sources
Mella JM et al. Efficacy and safety of finasteride therapy for androgenetic alopecia. Archives of Dermatology, 2010. Kaufman KD et al. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. European Journal of Dermatology, 2002. Olsen EA et al. The importance of dual 5-alpha-reductase inhibition in the treatment of male pattern hair loss. JAAD.org/” rel=”noopener” target=”_blank”>Journal of the AAD.org/” rel=”noopener” target=”_blank”>American Academy of Dermatology, 2006.